CIK: 0001560009
Total reported value
$141.4M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | BOLDEUR | Audentes Therapeutics INC | Stock-Other | 38.71% | — | — | |
| 2 | IMRX | Immuneering Corporation | Stock-Other | 17.69% | — | — | |
| 3 | AKAOQ | Achaogen INC | Stock-Other | 15.68% | — | — | |
| 4 | OCUL | Ocular Therapeutix INC | Stock-Other | 10.54% | — | — | |
| 5 | CLVSEUR | Clovis Oncology INC | Stock-Other | 6.38% | — | — | |
| 6 | CBAYUSD | Cymabay Therapeutics INC | Stock-Other | 6.29% | — | — | |
| 7 | ✓ | Second Sight Med Prods INC | Stock-Other | 4.10% | — | — | |
| 8 | ✓ | Opgen, Inc. | Stock-Other | 0.60% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | BOLDEUR | Audentes Therapeutics INC | +11.5% | — | Unchanged |
| 2 | CBAYUSD | Cymabay Therapeutics INC | +1.5% | — | Unchanged |
| 3 | IMRX | Immuneering Corporation | +0.9% | — | Unchanged |
| 4 | ✓ | Second Sight Med Prods INC | -0.3% | — | Unchanged |
| 5 | ✓ | Opgen, Inc. | -0.7% | — | Unchanged |
| 6 | CLVSEUR | Clovis Oncology INC | -1.1% | — | Unchanged |
| 7 | OCUL | Ocular Therapeutix INC | -5.6% | — | Unchanged |
| 8 | AKAOQ | Achaogen INC | -6.2% | — | Unchanged |